The relationship between inflammatory markers and post stroke cognitive impairment

Journal of Geriatric Psychiatry and Neurology

Volumn 23, Issue 3, 2010, Pages 199-205

  Rothenburg, Lana S ^a,b   Herrmann, Nathan ^a,b,c   Swardfager, Walter ^a,d   Black, Sandra E ^b,c,e   Tennen, Gayla ^a,b   Kiss, Alexander ^f   Gladstone, David J ^b,c,e   Ween, Jon ^c,e,g   Snaiderman, Abraham ^d,h   Lanctôt, Krista L ^a,b,c,d  

^a Neuropsychopharmacology Research Group   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c HEART AND STROKE FOUNDATION OF CANADA   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^g BAYCREST CENTRE FOR GERIATRIC CARE   (Canada)

^h TORONTO REHABILITATION INSTITUTE   (Canada)

Author keywords

cognitive impairment; cytokines; inflammation; stroke

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CEREBROVASCULAR DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CROSS-SECTIONAL STUDY; CYTOKINE PRODUCTION; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATION; LABORATORY TEST; MALE; MINI MENTAL STATE EXAMINATION; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RISK FACTOR; SERUM; STROKE;

ACTIVITIES OF DAILY LIVING; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-6; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SOCIOECONOMIC FACTORS; STROKE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77955521326     PISSN: 08919887     EISSN: 15525708     Source Type: Journal    
DOI: 10.1177/0891988710373598     Document Type: Article

References (41)

1. American Heart Association. Heart Disease and Stroke Statistics- 2009 Update (At-a-Glance Version). Dallas, TX: American Heart Association ; 2009.
2. Tatemichi TK, Desmond DW, Stern Y., Paik M., Sano M., Bagiella E. Cognitive impairment after stroke: frequency, patterns, and relationship to functional abilities. J Neurol Neurosurg Psychiatry. 1994 ; 57 (2). 202-207.
3. Hachinski V., Iadecola C., Petersen RC, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke. 2006 ; 37 (9). 2220-2241.
4. Khedr EM, Hamed SA, El-Shereef HK, et al. Cognitive impairment after cerebrovascular stroke: relationship to vascular risk factors. Neuropsychiatr Dis Treat. 2009 ; 5: 103-116.
5. Pohjasvaara T., Vataja R., Leppavuori A., Kaste M., Erkinjuntti T. Cognitive functions and depression as predictors of poor outcome 15 months after stroke. Cerebrovasc Dis. 2002 ; 14 (3-4). 228-233.
6. Nys GM, van Zandvoort MJ, van der Worp HB, et al. Early cognitive impairment predicts long-term depressive symptoms and quality of life after stroke. J Neurol Sci. 2006 ; 247 (2). 149-156.
7. Angelopoulos P., Agouridaki H., Vaiopoulos H., et al. Cytokines in Alzheimers disease and vascular dementia. Int J Neurosci. 2008 ; 118 (12). 1659-1672.
8. Schram MT, Euser SM, de Craen AJ, et al. Systemic markers of inflammation and cognitive decline in old age. J Am Geriatr Soc. 2007 ; 55 (5). 708-716.
9. Hoth KF, Haley AP, Gunstad J., et al. Elevated C-reactive protein is related to cognitive decline in older adults with cardiovascular disease. J Am Geriatr Soc. 2008 ; 56 (10). 1898-1903.
10. Tarkowski E., Rosengren L., Blomstrand C., et al. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke. 1995 ; 26 (8). 1393-1398.
11. Kostulas N., Pelidou SH, Kivisakk P., Kostulas V., Link H. Increased IL -1beta, IL-8, and IL-17 mRNA expression in blood mononuclear cells observed in a prospective ischemic stroke study. Stroke. 1999 ; 30 (10). 2174-2179.
12. Vila N., Castillo J., Davalos A., Chamorro A. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke. 2000 ; 31 (10). 2325-2329.
13. Idicula TT, Brogger J., Naess H., Waje-Andreassen U., Thomassen L. Admission C-reactive protein after acute ischemic stroke is associated with stroke severity and mortality: the Bergen stroke study. BMC Neurol. 2009 ; 9: 18.
14. Saito K., Markey SP, Heyes MP Chronic effects of gamma-interferon on quinolinic acid and indoleamine-2,3-dioxygenase in brain of C57BL6 mice. Brain Res. 1991 ; 546 (1). 151-154.
15. Foulkes MA, Wolf PA, Price TR, Mohr JP, Hier DB The Stroke Data Bank: design, methods, and baseline characteristics. Stroke. 1988 ; 19 (5). 547-554.
16. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. J Clin Epidemiol. 1988 ; 41 (2). 105-114.
17. Folstein MF, Folstein SE, McHugh PR "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 ; 12 (3). 189-198.
18. Radloff L. The centre for epidemiological studies depression scale. Appl Psychol Meas. 1977 ; 1 (3). 385-401.
19. Tombaugh TN, McIntyre NJ The mini-mental state examination: a comprehensive review. J Am Geriatr Soc. 1992 ; 40 (9). 922-935.
20. te Winkel-Witlox AC, Post MW, Visser-Meily JM, Linderman E. Efficient screening of cognitive dysfunction in stroke patients: comparison between the CAMCOG and the R-CAMCOG, Mini Mental State Examination and Functional Independence Measure-cognition score. Disabil Rehabil. 2008 ; 30 (18). 1386-1391.
21. Brott T., Adams HP Jr, Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989 ; 20 (7). 864-870. (Pubitemid 19188240)
22. Singh A., Black SE, Herrmann N., et al. Functional and neuroanatomic correlations in poststroke depression: the Sunnybrook Stroke Study. Stroke. 2000 ; 31 (3). 637-644.
23. Pucak ML, Kaplin AI Unkind cytokines: current evidence for the potential role of cytokines in immune-mediated depression. Int Rev Psychiatry. 2005 ; 17 (6). 477-483.
24. Hackett ML, Anderson CS Predictors of depression after stroke: a systematic review of observational studies. Stroke. 2005 ; 36 (10). 2296-2301.
25. Narushima K., Chan KL, Kosier JT, Robinson RG Does cognitive recovery after treatment of poststroke depression last? A 2-year follow-up of cognitive function associated with poststroke depression. Am J Psychiatry. 2003 ; 160 (6). 1157-1162.
26. Kivipelto M., Ngandu T., Fratiglioni L., et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol. 2005 ; 62 (10). 1556-1560. (Pubitemid 41434560)
27. Mangiafico RA, Sarnataro F., Mangiafico M., Fiore CE Impaired cognitive performance in asymptomatic peripheral arterial disease: relation to C-reactive protein and D-dimer levels. Age Ageing. 2006 ; 35 (1). 60-65.
28. Pepys MB, Hirschfield GM C-reactive protein: a critical update. J Clin Invest. 2003 ; 111 (12). 1805-1812.
29. Ridker PM, Cushman M., Stampfer MJ, Tracy RP, Hennekens CH Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997 ; 336 (14). 973-979.
30. van Dijk EJ, Prins ND, Vermeer SE, et al. C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation. 2005 ; 112 (6). 900-905.
31. Montecucco F., Steffens S., Burger F., Pelli G., Monaco C., Mach F. C-reactive protein (CRP) induces chemokine secretion via CD11b/ ICAM-1 interaction in human adherent monocytes. J Leukoc Biol. 2008 ; 84 (4). 1109-1119.
32. Elkins JS, OMeara ES, Longstreth WT Jr, Carlson MC, Manolio TA, Johnston SC Stroke risk factors and loss of high cognitive function. Neurology. 2004 ; 63 (5). 793-799.
33. Hofman A., Ott A., Breteler MM, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimers disease in the Rotterdam Study. Lancet. 1997 ; 349 (9046). 151-154. (Pubitemid 27039193)
34. Kearney-Schwartz A., Rossignol P., Bracard S., et al. Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints. Stroke. 2009 ; 40 (4). 1229-1236.
35. Markus HS, Hunt B., Palmer K., Enzinger C., Schmidt H., Schmidt R. Markers of endothelial and hemostatic activation and progression of cerebral white matter hyperintensities: longitudinal results of the Austrian Stroke Prevention Study. Stroke. 2005 ; 36 (7). 1410-1414.
36. Muir KW, Tyrrell P., Sattar N., Warburton E. Inflammation and ischaemic stroke. Curr Opin Neurol. 2007 ; 20 (3). 334-342.
37. Monje ML, Toda H., Palmer TD Inflammatory blockade restores adult hippocampal neurogenesis. Science. 2003 ; 302 (5651). 1760-1765.
38. Mungas D., Jagust WJ, Reed BR, et al. MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimers disease. Neurology. 2001 ; 57 (12). 2229-2235.
39. Morra JH, Tu Z., Apostolova LG, et al. Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimers disease, mild cognitive impairment, and elderly controls. Neuroimage. 2009 ; 45 (1 suppl). S3 - S15.
40. Marsland AL, Gianaros PJ, Abramowitch SM, Manuck SB, Hariri AR Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults. Biol Psychiatry. 2008 ; 64 (6). 484-490.
41. Schoenborn JR, Wilson CB Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol. 2007 ; 96: 41-101.